Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 21 Feb 2024

Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)

in Hematologic Malignancies

Lina Hollenbach
Julia Rogahn
Philipp le Coutre
Susann Schulze
Lars-Olof Muegge
Jan Geissler
Julia Gruen
Christian Junghanss
Sabine Felser

Frontiers in Oncology

doi 10.3389/fonc.2024.1345050

8,511 views
3 citations

Systematic Review

Published on 20 Feb 2024

Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia

in Hematologic Malignancies

Miguel Enrique Cuéllar Mendoza
Francisco Raúl Chávez Sánchez
Elisa María Dorantes Acosta
Ana María Niembro Zúñiga
Rosana Pelayo
Marta Zapata Tarrés

Frontiers in Oncology

doi 10.3389/fonc.2024.1304605

2,682 views
2 citations

Review

Published on 20 Feb 2024

Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy

in Hematologic Malignancies

Raffaele Palmieri
Atto Billio
Felicetto Ferrara
Sara Galimberti
Roberto M. Lemoli
Elisabetta Todisco
Federico Moretti
Adriano Venditti

Frontiers in Oncology

doi 10.3389/fonc.2024.1367393

4,789 views
2 citations

Editorial

Published on 19 Feb 2024

Editorial: Covid-19 therapies in patients with hematologic malignancies

in Hematologic Malignancies

Andrea Visentin
Massimo Gentile

Frontiers in Oncology

doi 10.3389/fonc.2024.1382268

1,537 views
2 citations

Review

Published on 19 Feb 2024

The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies

in Hematologic Malignancies

Jadwiga Filipek-Gorzała
Patrycja Kwiecińska
Agata Szade
Krzysztof Szade

Frontiers in Oncology

doi 10.3389/fonc.2024.1308709

10,569 views
19 citations

Editorial

Published on 16 Feb 2024

Editorial: Advances in predisposition to bone marrow failure and hematopoietic neoplasms

in Hematologic Malignancies

Sushree S. Sahoo
Sherif Abdelhamed
Makiko Mochizuki-Kashio
Lara Wahlster

Frontiers in Oncology

doi 10.3389/fonc.2024.1377974

1,711 views

Case Report

Published on 13 Feb 2024

Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report

in Hematologic Malignancies

Serena Vita
Alessandra D’Abramo
Andrea Coppola
Chiara Farroni
Anna Paola Iori
Francesca Faraglia
Alessandro Sette
Alba Grifoni
Cecilia Lindestam Arlehamn
Michele Bibas

Frontiers in Oncology

doi 10.3389/fonc.2024.1290614

1,901 views
4 citations

Case Report

Published on 12 Feb 2024

Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease

in Hematologic Malignancies

Yijun Cai
Amir Ali
Elan Filler
Rua Bayati
Tanjia Toma
Omar Zaki
George Yaghmour
Abdullah Ladha
Karrune Woan
Eric Tam

Frontiers in Oncology

doi 10.3389/fonc.2024.1329893

3,678 views
1 citation

Original Research

Published on 12 Feb 2024

Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study

in Hematologic Malignancies

Yu Ri Kim
Ho Jin Shin
Ho-Young Yhim
Deok-Hwan Yang
Yong Park
Ji Hyun Lee
Won-Sik Lee
Young Rok Do
Yeung-Chul Mun
Dae Sik Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1363385

3,079 views
1 citation

Case Report

Published on 09 Feb 2024

Successful avatrombopag combined with cyclosporine treatment for carboplatin/pegylated liposomal doxorubicin/bevacizumab-induced acquired amegakaryocytic thrombocytopenia in a patient with recurrent ovarian cancer: case report

in Hematologic Malignancies

Weikang Meng
Jinsheng Hua
Jiabing Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1253230

2,570 views
2 citations

Review

Published on 09 Feb 2024

Azacitidine induced lung injury: report and contemporary discussion on diagnosis and management

in Hematologic Malignancies

Ruah Alyamany
Ahmed Alnughmush
Malak Almutlaq
Mohammed Alyamany
Mansour Alfayez

Frontiers in Oncology

doi 10.3389/fonc.2024.1345492

5,297 views
4 citations

Review

Published on 09 Feb 2024

Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps

in Hematologic Malignancies

Salvatrice Mancuso
Marta Mattana
Federica Giammancheri
Federica Russello
Melania Carlisi
Marco Santoro
Sergio Siragusa

Frontiers in Oncology

doi 10.3389/fonc.2024.1201595

4,703 views
1 citation

Brief Research Report

Published on 08 Feb 2024

Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma

in Hematologic Malignancies

A. John Callegari
Josephine Tsang
Stanley Park
Deanna Swartzfager
Sheena Kapoor
Kevin Choy
Sungwon Lim

Frontiers in Oncology

doi 10.3389/fonc.2024.1304144

5,060 views
5 citations

Editorial

Published on 07 Feb 2024

Editorial: 50 years of BMT: conditioning regimens and early complications after transplantation

in Hematologic Malignancies

Michele Malagola
Raffaella Greco
Jean El Cheikh

Frontiers in Oncology

doi 10.3389/fonc.2024.1369573

1,859 views
1 citation

Case Report

Published on 07 Feb 2024

Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine

in Hematologic Malignancies

Lu Liu
Xiaofeng Song
Wenhao Dong
Zhao Li
Dongmei Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1353818

2,583 views
2 citations

Editorial

Published on 06 Feb 2024

Editorial: Decoding the genome of acute lymphoblastic leukemia through genomic and transcriptomic approaches

in Hematologic Malignancies

Silvia Jiménez-Morales
Augusto Rojas-Martinez
Gisela Barbany

Frontiers in Oncology

doi 10.3389/fonc.2024.1368676

1,514 views

Brief Research Report

Published on 02 Feb 2024

Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells

in Hematologic Malignancies

Eleonora Vecchio
Rossana Marino
Selena Mimmi
Camilla Canale
Carmen Caiazza
Alessandro Arcucci
Maria Rosaria Ruocco
Marco Schiavone
Gianluca Santamaria
Camillo Palmieri

Frontiers in Oncology

doi 10.3389/fonc.2024.1339584

2,449 views
2 citations

Editorial

Published on 02 Feb 2024

Editorial: Tyrosine kinases and phosphatases in T- cell malignancies

in Hematologic Malignancies

Melania Tesio

Frontiers in Oncology

doi 10.3389/fonc.2024.1372133

1,432 views

Original Research

Published on 01 Feb 2024

S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma

in Hematologic Malignancies

Qi Lin
Jianlin Su
Yuanyuan Fang
Zhihao Zhong
Jie Chen
Chaofeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1344669

4,071 views
3 citations

Case Report

Published on 01 Feb 2024

Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome

in Hematologic Malignancies

Leah Kogan
Russell Price
Rouslan Kotchetkov

Frontiers in Oncology

doi 10.3389/fonc.2024.1326209

2,865 views
1 citation

Original Research

Published on 01 Feb 2024

A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Jeong-Yeon Cho
Suk-Chan Jang
Dong-Won Kang
Eui-Kyung Lee
Hyein Koh
Dok Hyun Yoon
Mi-Hai Park

Frontiers in Oncology

doi 10.3389/fonc.2024.1282323

5,042 views
2 citations

Case Report

Published on 31 Jan 2024

Case report: Good response to CMOP regimen containing mitoxantrone hydrochloride liposome (PLM60) as induction chemotherapy in patients with angioimmunoblastic T-cell lymphoma

in Hematologic Malignancies

Lijie Liang
Ming Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1331154

2,462 views
2 citations

Original Research

Published on 30 Jan 2024

Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study

in Hematologic Malignancies

Suhyeon Kim
Jiye Jung
Seo-Yeon Ahn
Mihee Kim
So Yeon Jeon
Chang-Hoon Lee
Dae Sik Kim
Se Ryeon Lee
Hwa Jung Sung
Chul Won Choi

Frontiers in Oncology

doi 10.3389/fonc.2024.1307315

3,246 views
3 citations

Case Report

Published on 29 Jan 2024

Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature

in Hematologic Malignancies

Can Chen
Fan Yang
Peiwen Miu
Pengfei Shi
Shenxian Qian

Frontiers in Oncology

doi 10.3389/fonc.2024.1345464

3,455 views
3 citations

2,012 articles

articles

Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)

Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia

Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy

Editorial: Covid-19 therapies in patients with hematologic malignancies

The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies

Editorial: Advances in predisposition to bone marrow failure and hematopoietic neoplasms

Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report

Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease

Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study

Successful avatrombopag combined with cyclosporine treatment for carboplatin/pegylated liposomal doxorubicin/bevacizumab-induced acquired amegakaryocytic thrombocytopenia in a patient with recurrent ovarian cancer: case report

Azacitidine induced lung injury: report and contemporary discussion on diagnosis and management

Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps

Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma

Editorial: 50 years of BMT: conditioning regimens and early complications after transplantation

Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine

Editorial: Decoding the genome of acute lymphoblastic leukemia through genomic and transcriptomic approaches

Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells

Editorial: Tyrosine kinases and phosphatases in T- cell malignancies

S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma

Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome

A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma

Case report: Good response to CMOP regimen containing mitoxantrone hydrochloride liposome (PLM60) as induction chemotherapy in patients with angioimmunoblastic T-cell lymphoma

Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study

Allo-HSCT with TBI-based preconditioning for hepatosplenic T-cell lymphoma: two case reports and systematic review of literature